PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL, page-11

  1. 360 Posts.
    lightbulb Created with Sketch. 42
    Yes Moz the data is interesting, but none of the outcomes reached statistical significance, its only p<0.1. For full significance it needs to be p<0.05 or better. But none the less promising.
    So certainly trending in the right direction but because of the low animal numbers in each group the stats couldn't provide full statistical significance.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.